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a b s t r a c t
Understanding the host response to inﬂuenza A virus infection is essential for developing intervention
approaches. We show that infection of human alveolar epithelial cells and human bronchial epithelial
cells with inﬂuenza A for 3 h resulted in down-regulation of host hsa-miRNA-548an (miRNA-548an)
which triggered the overexpression of inﬂuenza non-structural-1A binding protein (IVNS1ABP, herein
referred to as NS1ABP). Reduced NS1ABP mRNA and NS1ABP protein expression after transfection of
miRNA-548an mimic or increased NS1ABP mRNA and NS1ABP protein expression after transfection of
miRNA-548an inhibitor provided evidence that miRNA-548an is involved in the regulation of NS1ABP.
Transfection of cells with inhibitor led to reduced apoptosis of infected cells while transfection of mimic
led to increased apoptosis and reduced inﬂuenza copy number suggesting that NS1ABP has a role in viral
maintenance. Thus, miRNA-548an may be an important target in controlling the early stage infection of
inﬂuenza A.
Published by Elsevier Inc.
Introduction
Inﬂuenza viruses, which belong to the Orthomyxoviridae family,
are human respiratory pathogens that cause both seasonal epidemics
and periodic pandemics (Taubenberger and Morens, 2008). Inﬂuenza
virus pandemics are responsible for substantial mortality and mor-
bidity, particularly in the high-risk groups. Antiviral response factors
in host cells signiﬁcantly down-regulate replication of the virus
in host tissues. A signiﬁcant increase in inﬂammatory cytokines is
documented during inﬂuenza infections (Gentile et al., 1998).
A recent RNA interference study revealed that the inﬂuenza virus
relies on speciﬁc host factors for replication and at least 295 cellular
factors were required for early stage viral replication (Konig et al.,
2010). Furthermore, several host cell genes are required for inﬂuenza
A survival and replication (Karlas et al., 2010).
A critical viral protein-host protein interaction is exempliﬁed in
the binding of inﬂuenza A non-structural protein-1 (NS1) with the
host cell inﬂuenza non-structural-1A binding protein (NS1ABP)
(Wolff et al., 1998). The inﬂuenza A NS1 gene has a signiﬁcant
impact on host cell gene expression and a central role in inhibiting
interferon (IFN) and other cytokines, and in activating NF-κB and
PI3-K pathways (Geiss et al., 2002; Shin et al., 2007). NS1 protein
localizes in the nucleus and to some extent in the cytoplasm of
infected cells (Compans, 1973; Krug and Etkind, 1973). NS1 is a
powerful translational enhancer that speciﬁcally induces viral
mRNAs (Das et al., 2008; Fortes et al., 1994). NS1also interacts
with cellular β-tubulin and disrupts the microtubule network and
induces apoptosis of A549 cells (Han et al., 2012). Another major
function of NS1 is the inhibition of pre-mRNA splicing (Fortes
et al., 1994). Nemeroff et al. proposed a regulatory action through
inhibition of host general gene expression by NS1 (Nemeroff
et al., 1998). The NS1 protein inhibits 3′ end processing and
the uncleaved pre-mRNA remains in the nucleus, thus NS1 could
selectively inhibit the nuclear export of cellular mRNAs (Nemeroff
et al., 1998). These actions appear to be mediated by binding with
the host cell NS1ABP. NS1ABP plays a key role in cell division and
in the dynamic organization of the actin skeleton as a stabilizer of
actin ﬁlaments, by association with F-actin through Kelch repeats.
NS1ABP protects cells from actin ﬁlament damage and cell death
induced by actin destabilization caused by actin-destabilizing
agents (Dunham et al., 2006; Wolff et al., 1998).
Despite the plethora of activities generated by the NS1 protein,
there is a lack of understanding of the molecular regulation of its
host cell binding protein. miRNAs have been implicated as impor-
tant regulators of mammalian antiviral responses even though their
precise role in the antiviral system has not been reported (Loveday
et al., 2012; Russo and Potenza, 2011). miRNAs are 21–23 nucleotide
single-stranded RNA molecules that negatively regulate gene
expression (Bartel, 2004). Each miRNA can inﬂuence hundreds of
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Fig. 1. Inﬂuenza A alters host miRNA expression. (A) PCR analysis of individual miRNAs that showed differential expression in microarray analysis. miRNA isolated after 3 h
of exposure to inﬂuenza A (A/WS/33 (H1N1), A/Aichi/2/68 (H3N2), A/Swine/1976/31 (H1N1), and A/Swine/Iowa/15/30 (H1N1)), (MOI of 3). The fold change represents
the change in miRNA expression in infected cells relative to that obtained in uninfected cells. (B) A549 cells were infected with 3MOIs of inﬂuenza A (A/WS/33 (H1N1),
A/Aichi/2/68 (H3N2), A/Swine/1976/31 (H1N1), and A/Swine/Iowa/15/30 (H1N1)), for 3 h and matrix copy numbers were determined by RT-PCR. (C) NS1ABP mRNA
expression was normalized to expression of GAPDH mRNA in response to 3MOI of inﬂuenza. Data are expressed as 7standard error of the mean (SEM). n¼4 (independent
experiments) with triplicate replicates (*¼po0.05, **¼po0.01, ***¼po0.001). (D) PCR analysis of individual miRNAs in human bronchial epithelial cells (HBEpC) exposed
to inﬂuenza A (A/WS/33 (H1N1), and A/Aichi/2/68 (H3N2)). miRNA isolated after 3 h of exposure to inﬂuenza A (MOI of 3). The fold change represents the change in miRNA
expression in infected cells relative to that of uninfected cells. (E) HBEpC cells were infected with 3 MOIs of inﬂuenza A for 3 h and matrix copy numbers were determined by
RT-PCR. (F) NS1ABP mRNA expression was normalized to expression of GAPDH mRNA in response to 3MOI of inﬂuenza A. po0.05 was considered signiﬁcant. The fold change
represents the change in miRNA and mRNA expression in infected cells relative to that of uninfected cells. Data are expressed as 7standard error of the mean (SEM). n¼4
(independent experiments) with triplicate replicates (*¼po0.05, **¼po0.01, ***¼po0.001).
S. Othumpangat et al. / Virology 447 (2013) 84–94 85
mRNA targets and regulate cellular processes by binding with the
3′UTRs of their target mRNAs causing translational repression of the
target mRNA through degradation or blocking (Selbach et al., 2008).
Evidence indicates that target degradation is the predominant form
of miRNA mediated translational repression (Lim et al., 2005).
miRNAs regulate numerous cellular processes, including develop-
ment, differentiation, proliferation, apoptosis, stress response, and
viral defense (Fabian et al., 2010).
In the present study, we tested the hypothesis that speciﬁc
miRNA species modulate the expression of NS1ABP in human
alveolar epithelial cells (A549 cells), a type II respiratory epithelial
model, and in primary human bronchial epithelial cells (HBEpC)
during inﬂuenza A infection. We show that NS1ABP mRNA is
regulated by host-encoded miRNA-548an and assess the func-
tional role of NS1ABP during the early stages of infection.
Results
Inﬂuenza A infection deregulates the host miRNA proﬁle
miRNA expression proﬁling using locked nucleic acid (LNA)
based miRNA array on A549 cells infected with inﬂuenza A at MOI
of 3 showed changes in miRNA expression as compared to that
found in uninfected cells. Most of the 2040 human miRNAs
included in the array did not show any signiﬁcant changes during
infection. We selected 11 miRNAs that showed differential expres-
sion upon microarray analysis and conﬁrmed these results by RT-
PCR with different strains of inﬂuenza A (Fig. 1A) on A549 cells.
A549 cells showed an increase in expression of NS1ABP (Fig. 1C)
and also an increase in copy numbers during the 3 h infection with
different strains of inﬂuenza A virus (Fig. 1B). A similar pattern
in miRNA and NS1ABP expression was observed when the
primary human bronchial epithelial cells were exposed to H1N1
and H3N2 strains of inﬂuenza A (Fig. 1D–F). On exposure to
inﬂuenza A, miRNA-4423 showed increased expression in HBEpC
cells, whereas it signiﬁcantly decreased in A549 cells. Expression
of hsa-miR-548an was signiﬁcantly downregulated in both cell
lines with all strains of inﬂuenza A studied.
The Target scan database (www.targetscan.org) was used for
identifying potential direct miRNA targets. Of the 11 individual
miRNAs we examined, hsa-miR548an (miRNA-548an) was identi-
ﬁed to have a possible inﬂuenza related target, inﬂuenza A NS1
binding protein (IVNS1ABP – Gene bank accession NM_006469),
therefore further studies focused on miR-548an. The role of inﬂu-
enza on the expression of miR-548an and NS1ABP was assessed by
infecting A549 cells with increasing MOIs of inﬂuenza A (Fig. 2).
At very low MOI's (r0.01) where most cells are uninfected,
differences in expression of miRNA-548an and NS1ABP mRNA
were more difﬁcult to detect during the time points studied.
At MOI's Z0.1, the results showed a MOI dependent down-
regulation of miRNA-548an with the highest down-regulation
(po0.001) at an MOI of 1 (Fig. 2A). An inverse correlation between
miR-548an down-regulation and up-regulation of NS1ABP mRNA
was seen (Fig. 2B). At MOIs of 1 and 3 there were 2-fold increases
(po0.001) in NS1ABP mRNA expression during inﬂuenza A infec-
tion which was in agreement with the down-regulation of miR-
548an. Changes in NS1ABP expression with lower MOIs were
equally comparable to the levels of miRNA-548an expression.
The matrix gene copy number increased with increase in MOI
(Fig. 2C).
To further understand the regulation of NS1ABP mRNA expres-
sion with exposure time to the virus, we examined the kinetics of
the NS1ABP mRNA response along with miRNA-548an expression.
Down-regulation of miRNA-548an was evident after 1 h of expo-
sure to inﬂuenza A and decreased to the lowest point by 3 h
(Fig. 3A). In contrast, NS1ABP expression increased 1.5-fold after
1 h of exposure, and the maximal increase of 2.25-fold expression
was seen at 3 h (po0.001) (Fig. 3B). Thereafter, as seen with
expression of miRNA-548an, expression of NS1ABP mRNA to the
Fig. 2. miRNA-548an and NS1ABP mRNA expressions in A549 cells infected with different MOIs of inﬂuenza A. Differentially expressed miRNAs identiﬁed in the microarray
analysis were screened for a potential role in inﬂuenza propagation and miRNA-548anwas selected for further analysis. A549 cells were infected for 3 h with increasing MOIs
of inﬂuenza. (A) miRNA-548an expression in uninfected and infected A549 cells was normalized to expression of let-7 as a housekeeping miRNA. (B) NS1ABP mRNA
expression was normalized to expression of GAPDH mRNA in response to increasing MOIs of inﬂuenza. po0.01 was considered signiﬁcant. The fold change represents the
change in miRNA and mRNA expression in infected cells relative to that obtained in uninfected cells. (C) A549 cells were infected with 3 MOIs of inﬂuenza A for 3 h and
matrix copy numbers were determined by RT-PCR. Data are expressed as 7SEM. **¼po0.01, ***¼po0.001. n¼4 (independent experiments) with triplicate replicates.
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level seen in uninfected cells. An increase in matrix gene copy
number with increasing incubation time was observed at all time
points studied (Fig. 3C). There was also a 2-fold increase in the
level of NS1ABP protein measured by ﬂow cytometry as the mean
ﬂuorescent intensity (MFI) of cells exposed to inﬂuenza was
almost doubled (from 14 to 28, po0.01) on 3 h of exposure to
the virus (data not shown). Western blot analysis showed a similar
trend as ﬂow cytometry and was in corroboration with the mRNA
expression (Fig. 3D).
NS1ABP expression is regulated by miRNA-548an
To conﬁrm that miRNA-548an regulates expression of NS1ABP
mRNA, A549 cells were transfected with either an inhibitor
oligonucleotide speciﬁc for miRNA-548an or with a scrambled
oligonucleotide control and the expression of NS1ABP mRNA was
assessed by RT-PCR. At 50 nM inhibitor, expression of NS1ABP
mRNA increased 1.4-fold above that seen with cells exposed to the
scrambled oligonucleotide (Fig. 4A). Since cells infected with
inﬂuenza A have an increased level of NS1ABP mRNA presumably
because miRNA-548an decreases (Fig. 2), then infected cells
should show a further increase in NS1ABP mRNAwhen transfected
with the inhibitor. As shown, when inﬂuenza A was infected into
cells exposed to the inhibitor, there was a signiﬁcant (po0.001)
1.6-fold further increase in the level of NS1ABP mRNA relative to
that seen in infected cells transfected with a scrambled oligonu-
cleotide (Fig. 4B), consistent with the results shown in (Fig. 2).
We further conﬁrmed the role of miRNA-548an in regulating the
expression of NS1ABP mRNA by transfecting the cells with an
oligonucleotide mimic speciﬁc for miRNA-548an. Transfection of
25 nM miRNA-548an mimic into uninfected A549 cells signiﬁ-
cantly (po0.001) decreased the expression of NS1ABP mRNA by
465% (Fig. 4C). When inﬂuenza A was infected into cells trans-
fected with the mimic, there was a signiﬁcant (po0.001) further
decrease in expression of NS1ABP mRNA by 450% relative to that
seen in infected cells transfected with a scrambled oligonucleotide
(Fig. 4D). To further evaluate the stability of miRNAs in cells
transfected with mimic or inhibitor, we analyzed the expression
levels of NS1ABP. Data indicated that the miRNA mimic and
inhibitor were stable over a time period of 48 h, as represented
by the stability of NS1ABP expression (Fig. 4E and F).
In comparison to the NS1ABP mRNA expression, the ﬂow
cytometry data showed a similar effect on NS1ABP protein
expression. Uninfected A549 cells transfected with 50 nM
miRNA-548an inhibitor showed an up-regulation of NS1ABP
protein (Fig. 5A) and transfection with 25 nM of miRNA-548an
mimic showed a decrease in the expression of NS1ABP protein
(Fig. 5B). A549 cells transfected with miRNA-548an inhibitor and
exposed to inﬂuenza A showed signiﬁcantly higher NS1ABP
protein expression compared to infected cells transfected with
the scrambled oligonucleotide (po0.001) (Fig. 5C). Further,
infected A549 cells transfected with miRNA-548an mimic showed
signiﬁcantly lower (po0.01) NS1ABP protein expression com-
pared to infected cells transfected with the scrambled oligonu-
cleotide (Fig. 5D). A graphical analysis of these results shows
the mean ﬂuorescent intensity (MFI) of cells transfected with
inhibitor was 2-fold higher than that of cells transfected with the
scrambled oligonucleotide (po0.001); whereas cells transfected
with miRNA-548an mimic had a signiﬁcant reduction in NS1ABP
protein expression (Fig. 5E). Our data demonstrate that miRNA-
548an regulates the expression of NS1ABP protein in A549 cells.
The combined effect of miR-548an on NS1ABP protein expres-
sion and virus maintenance in A549 cells infected with inﬂuenza A
for 3 h was visualized by confocal microscopy (Fig. 6). Most of the
A549 cells transfected with the scrambled oligonucleotide miRNA
showed intense green ﬂuorescence as a result of active virus
infection and intense overlapping red ﬂuorescence generated by
concomitant overexpression of virus nucleoprotein (NP) (top
panels). In contrast, NS1ABP protein expression was reduced in
A549 cells transfected with miR-548an mimic, and this was
Fig. 3. Time course showing the expression levels of miRNA-548an and NS1ABP mRNA in cells infected with inﬂuenza A. (A) A549 cells were infected with 1 MOI of
Inﬂuenza A and expression of miRNA-548an normalized to let-7 miRNA is shown over 0–6 h of infection. (B) A549 cells were infected with 1 MOI of Inﬂuenza A and
expression of NS1ABP mRNA normalized to GAPDH mRNA is shown over 0–6 h of infection. The fold change represents the change in miRNA and mRNA expression in
infected cells relative to that obtained in uninfected cells. (C) HBEpC cells were infected with 3 MOIs of inﬂuenza A for 3 h and matrix copy numbers were determined by
RT-PCR. (D) Protein expression by Western blot analysis in cells infected with inﬂuenza A for up to 3 h and α-tubulin was used as a loading control. Data are expressed
as 7SEM. ***¼po0.001, **¼po0.01, *¼po0.05; n¼3 (independent experiments) with triplicate replicates.
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associated with a sharp reduction in the proportion of infected
cells (2nd row panels). Contrary to the results with the mimic,
there was higher expression of NS1ABP protein in cells transfected
with the miRNA-548an inhibitor that was associated with an
increase in the proportion of infected cells with NP now exclu-
sively localized to the nucleus (3rd row panels). The bottom panel
represents uninfected cells stained for NS1ABP protein.
NS1ABP functions as anti-apoptotic protein
NS1ABP may function as an anti-apoptotic protein during
inﬂuenza infection to protect the cells from undergoing apoptosis.
We veriﬁed the functional role of NS1ABP in early stage infection
of A549 cells by subjecting the infected cells to apoptosis and
necrosis assay. Inﬂuenza A infected cells transfected with miR-
548an mimic (Fig. 7) were more prone to apoptosis (48%)
compared to cells transfected with the scrambled oligonucleotide
(41%). Furthermore, 77% of cells transfected with miRNA-548an
inhibitor survived compared to 67% of cells transfected with the
scrambled oligonucleotide. The increased survival can be attrib-
uted to the increased expression of NS1ABP which may function as
an anti-apoptotic protein and prevent cells from going into
apoptosis. In contrast, the levels of necrotic cells did not change
irrespective of transfection with miR-548an mimic or inhibitor.
Moreover, the levels of apoptotic cells were comparatively lower in
cells transfected with the inhibitor (22%) compared to cells
transfected with the scrambled oligonucleotide (33%).
The increase in apoptosis when mimic was used to lower the
expression of NS1ABP was accompanied by a reduction in viral
copy number (Fig. 8). Cells transfected with 25 nM miRNA-548an
mimic and then infected with a low MOI of 0.01 showed 45%
reduction in viral copy numbers compared to infected cells
transfected with the scrambled oligonucleotide. The effect of the
mimic was effectively reduced by increasing the MOI (Fig. 8).
There was no signiﬁcant difference in viral copy number between
infected cells transfected with scrambled oligonucleotide and
infected cells that were not transfected with miRNA-548an or
scrambled oligonucleotide (data not shown).
Discussion
Although the biological functions of most miRNAs are
unknown, their importance for molecular regulation of differen-
tiation, cell proliferation, and cell death has been well documented
(Callis et al., 2007). Inﬂuenza virus regulates the functions of
certain genes in host organisms by high-jacking the protein
synthesis machinery, which is essential for viral propagation.
In addition to modifying host mRNA expression, the virus also
alters its protein proﬁle. We focused on a host protein that is
required for viral function and the miRNA that controls its
expression. Down-regulation of miRNA-548an, a miRNA not well
studied, had a signiﬁcant role in regulating viral copy number in
early stages of infection. MiRNA-548an has been predicted as a
target for the degradation of NS1ABP mRNA. Our data demonstrate
Fig. 4. Down or up-regulation of miRNA 548an alters the expression of NS1ABP mRNA. (A) Uninfected A549 cells were transfected for 48 h with 50 nM or 100 nM of either
miRNA 548an inhibitor or a scrambled oligonucleotide as control. Expression of NS1ABP mRNA normalized to GAPDH mRNA is shown. (B) After 48 h, transfected cells were
infected with 1 MOI of inﬂuenza A for 3 h. Expression of NS1ABP mRNA normalized to GAPDH mRNA is shown. n¼3 (independent experiments) with triplicate replicates.
(C) A549 cells were transfected for 48 h with 12.5 nM, 25 nM, or 50 nM of miRNA-548an mimic or scrambled oligonucleotide as control. Expression of NS1ABP mRNA
normalized to GAPDH mRNA is shown. (D) A549 cells were transfected for 48 h with miRNA-548an mimic or scrambled oligonucleotide. After 48 h, cells were infected with
1 MOI of inﬂuenza A for 3 h. Expression of NS1ABP mRNA normalized to GAPDH mRNA is shown. (E) NS1ABP expression proﬁle after 30 and 48 h of transfection with mimics
in A549 cells. (F) NS1ABP expression proﬁle after 30 and 48 h of transfection with inhibitor in A549 cells. The fold change represents the change in NS1ABP mRNA expression
and inﬂuenza A Matrix copy number in cells transfected with the inhibitor relative to that obtained in cells transfected with the scrambled oligonucleotide. Data are
expressed as 7SEM, **¼po0.01 and *¼po0.05. n¼4 (independent experiments) with triplicate replicates.
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that lower levels of miR-548an increase the expression of NS1ABP
and protect the cells from apoptotic cell death in the early stages
of infection (3 h), which is essential for viral particle assembly and
propagation. Our data suggests that the decreased expression of
miR-548an was not inﬂuenza A strains or cell line dependent.
We showed that decreased apoptosis in the early stages of
infection enhanced infectivity and/or viral maintenance. A recent
study implicated inﬂuenza A nucleoprotein and its interaction
with host clusterin protein in the induction of early apoptosis
(Tripathi et al., 2013).
NS1ABP has multiple functions in the cells, and although its
ligand, NS1, has been well characterized, the literature lacks
studies on NS1ABP which could represent a good target to control
infection of the virus. The miRNA548an mimic, which decreases
NS1ABP mRNA and protein levels, was found to signiﬁcantly
reduce the maintenance of inﬂuenza A virus in A549 cells
suggesting its use as a therapeutic intervention in the early stages
of infection. With antigenic drift and draft of the viral genes each
season, a solution to control viral infection may be through
modulation of host resistance by decreasing the possibility of viral
multiplication in the early stages of infection through exogenous
supplementation of miRNAs. The role of NS1ABP as an anti-
apoptotic protein in infected cells was demonstrated following
its down-regulation by exogenous supplementation of miRNA-
548an (transfection of mimic) which led to enhanced apoptosis. In
the presence of miRNA 548an inhibitor, the expression of NS1ABP
was signiﬁcantly increased and a concordant increase in cell
survival was observed. Interestingly, the relocation of NS1ABP
throughout the cytoplasm was proposed to result in functional
changes (Wolff et al., 1998), which was very similar to our ﬁndings
(Fig. 6). The extended lifespan of cells due to decreased apoptosis
would allow the virus to propagate for a longer period of time. The
anti-apoptotic properties are favorable for the early life-cycle of
the virus, which is reminiscent of the effect of anti-apoptotic
proteins on respiratory syncytial virus infection (Othumpangat
et al., 2012). Induction of apoptosis by inﬂuenza virus has been
reported in numerous cells both in vitro (Roulston et al., 1999) and
in vivo (Yang et al., 2011). Interaction of the NS1 protein with
β-tubulin in cells infected with inﬂuenza disrupted cell division
and induced apoptosis in A549 cells (Han et al., 2012). One
scenario is that an increased expression of NS1ABP and its
subsequent binding to NS1 may decrease the availability of NS1
to induce apoptosis.
MiRNAs affect a multitude of genes and regulate cellular
physiology through different mechanisms (Ambros, 2003; Bartel,
2004; Lai, 2003). Each miRNA is potentially able to bind up to
hundreds of partially complimentary mRNA transcripts and target
them for degradation (He and Hannon, 2004). Studies on the
functions of miR-548an are sparse in the literature, though the
Target Scan database showed hundreds of targets for this miRNA.
We focused on miR-548an as it was signiﬁcantly down-regulated
during the early stages of infection. Moreover, its overexpression
(by transfecting with its mimic) showed less susceptibility to
viral attack while the reverse (by transfecting with the inhibitor)
increased inﬂuenza maintenance and demonstrated that decrea-
sed expression of NS1ABP enables cells to block propagation at
least in the early stages of an infection. The exogenous adminis-
tration of synthetic miRNAs in the form of mimics may antagonize
Fig. 5. NS1ABP protein expression is modulated by miRNA 548an. (A) Flow cytometry analysis of A549 cells transfected for 48 h with 50 nM miRNA-548an inhibitor or
scrambled oligonucleotide. (B) Flow cytometry analysis of A549 cells transfected for 48 h with 25 nM miRNA-548an mimic or scrambled oligonucleotide. (C) Flow cytometry
analysis of A549 cells transfected for 48 h with 50 nM miRNA-548an inhibitor and then infected with 1 MOI of inﬂuenza for 3 h. Expression of NS1ABP protein in cells
transfected with the miRNA-548an inhibitor (green line), or scrambled oligonucleotide as control (black line) is shown. (D) Flow cytometry analysis in A549 cells transfected
for 48 h with miRNA-548an mimic (green line) or scrambled oligonucleotide (black line) and then infected with 1 MOI of inﬂuenza for 3 h. The gray shaded or red shaded
regions in the graph represent the isotype control. (E) Geometric mean ﬂuorescent intensity (MFI) was measured from 3 independent experiments with triplicate replicates.
###¼po0.001whencomparing cells transfected with inhibitor to cells transfected with the scrambled oligonucleotide; ##¼po0.01when comparing cells transfected with
mimic to cells transfected with the scrambled oligonucleotide **¼po0.01 when comparing cells transfected with mimic or inhibitor.
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inﬂuenza replication in airway epithelium, and provide a novel
strategy for therapy for the ﬂu. Based on our ﬁndings, we
speculate that miR-548an may play a vital role in reducing the
symptoms of inﬂuenza infection such as acute bronchiolitis and
possibly its chronic sequelae including post-severe bronchitis.
There are several other miRNAs that are reported to have a role
in the life cycle of the inﬂuenza virus, and these or other
unidentiﬁed miRNAs may also affect programmed cell death and
viral replication. Deciphering the regulation of miRNA expression
may be important not only for diagnostic but also for therapeutic
purposes (Janssen et al., 2013; Kasinski and Slack, 2011).
During viral replication, miRNA patterns expressed by infected
cells can inﬂuence the ability of the invading virus to propagate
and survive (Triboulet et al., 2007). Several DNA viruses including
herpes viruses encode their own miRNAs that can alter or saturate
the miRNA composition of host cells (Ghosh et al., 2009). The host-
cellular miRNAs modulate the expression of various viral genes
and play a pivotal role in the host-pathogen interaction network.
Thus, both the virus and the host are able to manipulate the
miRNAs as part of their evolutionary strategies for survival, and in
fact both virus-encoded and cell encoded miRNAs are key for
prolonging host cell survival. Inﬂuenza does not encode any
miRNAs but is capable of inducing the expression of 18–27
nucleotide viral leader RNAs, which are incapable of functioning
as miRNAs (Umbach et al., 2010). But inﬂuenza virus can alter the
miRNA proﬁle of the host which, in turn, can directly alter the
virus life cycle (Gottwein and Cullen, 2008). A recent clinical study
using small inhibitory RNA complimentary to the mRNA encoding
respiratory syncytial virus (RSV) protein demonstrated feasibility
and potential efﬁcacy of delivering small RNAs directly to the
airway mucosa (Zamora et al., 2011). Human miRNAs with anti-
viral effects thus have signiﬁcant potential to use as new strategies
for antiviral intervention.
In normal cells NS1ABP is concentrated in the intra-nuclear
domain, an area enriched with multiple splicing factors. During
inﬂuenza infection NS1ABP is re-localized which may alter its
functional role. Wolff et al. (1998) have proposed that NS1 may
down-regulate NS1ABP activity directly by blocking its normal
association with spliceosomes. We overexpressed NS1 by trans-
fecting A549 cells with an NS1 expression plasmid and also
showed that NS1ABP was signiﬁcantly down-regulated (data not
shown). Wolff et al. (1998) showed that expression of NS1
increases in the later stages of infection but whether NS1 acts by
inducing miRNA548an expression is unclear.
In conclusion, our data show that inﬂuenza infection modiﬁes
miRNA expression patterns in the human lung epithelium. Down-
regulation of one miRNA, miRNA-548an, led to increased expres-
sion of NS1ABP which favors anti-apoptosis of host cells and
increased viral maintenance. That miRNAs are involved in regulat-
ing viral replication which has been shown in other viral systems
Fig. 6. Visualization of NS1ABP protein expression following modulation of miRNA-548an. A549 cells were transfected for 48 h with either the scrambled oligonucleotide
(negative control) (top panel), miRNA-548an mimic (middle panel), or miRNA-548an inhibitor (third panel), and uninfected cells (bottom panel). Transfected cells were
infected 1 MOI of inﬂuenza A for 3 h and expression of NS1ABP protein (green) and inﬂuenza nucleoprotein (red) was determined by immunoﬂuorescence. DAPI (blue)
represents the stained nucleus of the cells (not shown separately).
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including Hepatitis C and HIV-1 (Jopling et al., 2006; Roberts et al.,
2011; Triboulet et al., 2007). Our ﬁndings provide a better under-
standing of the regulatory mechanisms that contribute to the host
response to viral infection and disease pathogenesis, and may
provide a basis for the development of safe and effective inter-
vention strategies to block inﬂuenza infection through the delivery
of synthetic miRNAs in inﬂuenza infections.
Material and methods
Cell culture
Human alveolar epithelial A549 cells (CCL-34), American Type
Culture Collection [ATCC, Manassas, VA] were cultured in standard
F12K medium containing 10% heat-inactivated fetal bovine serum
(FBS), 100 IU/ml penicillin and 100 mg/ml streptomycin sulfate.
Madin-Darby canine kidney (MDCK) cells were used for the
propagation of inﬂuenza virus. MDCK cells were cultivated in
MEM (ATCC) supplemented with 10% FBS and100 IU/ml penicillin
and 100 mg/ml streptomycin sulfate.
Human bronchial epithelial cells (HBEpC) were purchased from
Promo Cell (Heidelberg, Germany) and were maintained in the
recommended media and supplements provided by the vendor.
Conﬂuent plate of human bronchial epithelial cells was incub-
ated with 3 MOI (multiplicity of infection) of inﬂuenza viruses
(A/WS/33 and A/Aichi/2/68).
Inﬂuenza A virus
Inﬂuenza strain A/WS/33 (H1N1, ATCC VR-825), lot 58023547
at 1.58108 50% chicken embryo infectious dose 50% endpoint
(CEID50)/ml and lot 58772128 at 2.8106 [CEID]50/ml, A/Aichi/2/
68 (H3N2, ATCC-1680), A/Swine/1976/31 (H1N1, ATCC 1682), and
A/Swine/Iowa/15/30 (H1N1, ATCC 1683) were purchased from the
ATCC and maintained as described (Blachere et al., 2009, 2011).
miRNA array proﬁling
miRNA microarray analysis of the A549 cells infected with
inﬂuenza virus (A/WS/33) was performed by Exiqon (Vedbaek,
Denmark). Brieﬂy, A549 cells in 6 well plates were infected with
inﬂuenza A at a multiplicity of infection (MOI) of 3 for 3 h and RNA
was extracted from the infected and control cells using the Exiqon
miRCURY LNA miRNA extraction kit (Exiqon). The quality of the
total RNA was veriﬁed by an Agilent 2100 Bioanalyzer proﬁle.
750 ng of total RNA from both sample and reference was labeled
with Hy3™ and Hy5™ ﬂuorescent label, respectively, using the
Fig. 7. Apoptotic pattern of cells transfected with miRNA-548an mimic or inhibitor and infected with inﬂuenza A. (A and C) A549 cells were transfected for 48 h with the
scrambled oligonucleotide or (B) miRNA-548an mimic, or (D) miRNA-548an inhibitor. Transfected cells were then infected with 1 MOI of inﬂuenza A for 3 h. The cells were
immune-ﬂuorescently labeled with annexin V and apoptotic cells were analyzed by ﬂow cytometry. Transfection did not change the proportion of necrotic cells detected by
propidium iodide (PI) staining. Graph is a representative plot from 3 independent experiments and data presented as percentage of cells in each quadrant. Left upper
quadrant¼necrotic cells; left lower quadrant¼viable cells; right lower quadrant¼apoptotic cells; right upper quadrant¼ late apoptotic cells in necrotic state.
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miRCURY LNA™ microRNA Hi-Power Labeling Kit, Hy3™/Hy5™
(Exiqon) following the procedure described by the manufacturer.
The Hy3™-labeled samples and a Hy5™-labeled reference RNA
sample were mixed pair-wise and hybridized to the miRCURY
LNA™ microRNA Array 7th gen (Exiqon), which contains capture
probes targeting all microRNAs for human, mouse or rat registered
in the miRBASE 16.0. The hybridization was performed according
to the miRCURY LNA™microRNA Array instruction manual using a
Tecan HS4800™ hybridization station (Tecan, Mannedorf, Switzer-
land). After hybridization the microarray slides were scanned and
stored in an ozone free environment (ozone level below 2.0 ppb)
in order to prevent potential bleaching of the ﬂuorescent dyes. The
miRCURY LNA™ microRNA Array slides were scanned using the
Agilent G2565BA Microarray Scanner System (Agilent Technolo-
gies, Inc., Santa Clara, CA) and the image analysis was carried out
using the ImaGenes 9 (miRCURY LNA™ microRNA Array Analysis
Software, Exiqon). The quantiﬁed signals were background cor-
rected (Norm expressed with offset value 10) and normalized
using the global Lowess (Locally Weighted Scatterplot Smoothing)
regression algorithm. The data obtained were subjected to statis-
tical analysis and differentially regulated miRNAs in infected and
uninfected cells were identiﬁed and reported.
RNA isolation for miRNA studies
Total RNA (including miRNA) was extracted from the control and
infected cells (performed in triplicate) using the miRCURY™ RNA
extraction kit (Exiqon). cDNA was synthesized using the universal
cDNA kit from Exiqon, diluted and used for real time SYBR green
(Exiqon) PCR as instructed by the supplier. Forward and reverse
primers for miRNA analysis were purchased from Exiqon. Real time
quantitation of miRNAs were done using power SYBR green PCR
master mix on a real time PCR 7500 ABI (Applied Biosystems, Foster
City, CA). miRNA let-7 was used as the internal control. The fold
change in expression of miRNA was calculated as described below.
Quantitative real time (RT) PCR analysis
Total RNA was isolated from A549 and HBEpC cells using the
RNeasy kit (Qiagen, Valencia, CA) and cDNA synthesized using the
ABI-RT PCR kit (Applied Biosystems) were used for mRNA expres-
sion studies. RT-PCR reactions were carried out using the TaqMan
FAST PCR reagent (Applied Biosystems) and the ABI 7500 FAST
real-time cycler (Applied Biosystems). TaqMan primers for NS1ABP
and glyceraldehyde phosphate dehydrogenase (GAPDH) were
purchased from Applied Biosystems. Transcript expression was
normalized using GAPDH as the housekeeping gene. The relative
change in gene expression was calculated using the formula: fold
change¼2^(ddCt)¼2dCt (treated samples)2dCt (control sam-
ples), where dCt¼Ct (detected gene)Ct (GAPDH) and Ct is the
threshold number. Cycle threshold (Ct) values were calculated
with the SDS software using automatic baseline settings with
assigned minimum threshold.
Inﬂuenza copy number was calculated based on the matrix
gene copy number, using the following matrix-speciﬁc primers:
Forward 5′AGATGAGTCTTCTAACCGAGGTCG3′, Reverse 5′TGCAA-
AAACATCTTCA AGTCT CTG3′ and probe: 6FAM-TCAGGCCCC-
CTCAAAGCCGA-MGBNFQ (Spackman et al., 2002). All primers
and probes were synthesized by Applied Biosystems and used at
a ﬁnal concentration of 0.8 μM and 0.2 μM, respectively. Reactions
were performed and analyzed using the Applied Biosystems 7500
Fast Real-Time PCR. To determine the relative gene copy number
from strains A/WS/33-infected A549 cells, a standard curve was
generated from the cloned inﬂuenza H1N1 matrix gene and
analyzed concurrently with RT-PCR reactions (Blachere et al.,
2009).
Transfection studies
A549 cells were transfected with a miRNA-548an inhibitor
oligonucleotide (complementary strand to miRNA-548an) or a
miRNA-548an mimic oligonucleotide (corresponding to the
miRNA-548an sequence) (Life Technologies, Carlsbad, CA) using
the lipid-based Lipofectamine 2000 reagent diluted in Opti-MEM-I
reduced serum medium (Life Technologies) according to the
protocol provided by the supplier. Brieﬂy, A549 cells were grown
to 80% conﬂuence in 6-well plates. Transfection complexes were
directly applied to the cells (ﬁnal concentration of 0–100 nM) and
the plates were incubated in a humidiﬁed chamber with 5% CO2 at
37 1C. After 6 h of transfection, the medium was replaced with
fresh complete MEM medium. As negative control, cells were
transfected with a scrambled oligonucleotide (Life Technologies).
To evaluate the effects of miRNA-548an in the context of viral
infection, cells after 48 h of transfection were infected with
inﬂuenza A at an MOI of 1. Virus were allowed to attach to the
cells for 45 min at 37 1C, then the excess virus was washed off and
fresh MEM medium containing 1 mg/mL of TPCK trypsin (Sigma,
St. Louis, MO) was added. Cells were then incubated for another
3 h. Following the incubation, cells were harvested by trypsiniza-
tion, washed with phosphate buffered saline (PBS) and used for
RNA extraction or ﬂow cytometry.
Flow cytometric analysis
A549 cells were transfected for 48 h with mimic, inhibitor or
the scrambled control oligonucleotide and, in some experiments,
transfected cells were then infected for 3 h with inﬂuenza A. Cells
were isolated by trypsinization and stained with speciﬁc antibo-
dies for NS1ABP (Abcam, Cambridge, MA). Rabbit IgG (Sigma,
St Louis, MO) was used as isotype control for detection of non-
speciﬁc binding. Secondary antibody labeled with Alexaﬂour-488
was purchased from Life Technologies. Brieﬂy, 5106 cells
infected with inﬂuenza A were washed in 2 ml PBS, pelleted by
centrifugation, resuspended in 10% formaldehyde, and held for
30 min in ice. Cells were permeabilized using 70% cold ethanol
for 30 min, washed with PBS, and then blocked with 0.1% BSA for
Fig. 8. Effect of miRNA 548an mimic on viral replication. (A) A549 cells were
transfected for 48 h with 25 nM miRNA-548an mimic or a scrambled oligonucleo-
tide. After 48 h, the cells were infected with increasing MOIs of inﬂuenza A for 3 h
and matrix copy numbers were determined by RT-PCR. Expression of inﬂuenza
Matrix gene copies in cells transfected with the mimic is expressed relative to that
obtained in cells transfected with the scrambled oligonucleotide. Data are
expressed as 7SEM, **¼po0.01, and *¼po0.05. n¼3 (independent experiments)
performed in triplicate.
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15 min. Following blocking, primary antibody was added diluted
in PBS-BSA solution. After 20 min of incubation on ice, cells were
washed with PBS containing 0.2% tween20. The cells were treated
with ﬂuorescently-labeled secondary antibody and held in the
dark for 20 min. Unbound antibody was washed with PBS-tween
and the resulting cell pellet was reconstituted in 300 uL of PBS.
Data were acquired using a FACSCalibur instrument (BD Bios-
ciences, San Jose, CA). A minimum of 10,000 events were collected
per sample. Non-infected cells were used to establish the back-
ground level of ﬂuorescence in the FL-1 channel (488 nm). Data
were analyzed with Windows Multiple Document Interface ver-
sion 2.9 software for ﬂow cytometry (Win MIDI, La Jolla, CA), and
the mean ﬂuorescent intensity was calculated using the same
software.
Western blotting
IVNS1ABP protein in infected A549 cells was analyzed by
Western blot under reducing conditions using goat anti-rabbit
anti-IVNS1ABP antibody (Abcam, MA). NS1ABP protein levels were
examined using 30 μg of whole cell homogenates. α-Tubulin or
GAPDH (SantaCruz, CA) served as a loading controls. The immu-
noreactive bands were detected using enhanced chemilumines-
cence (ECL, Thermoscientiﬁc).
Imaging with confocal microscopy
A549 cells were grown on chamber slides (Chamber slide™,
Lab-TekII, Thermo Fisher Scientiﬁc, Rochester, NY) and transfected
for 48 h with the miRNA-548an inhibitor, mimic or scrambled
oligonucleotide. The transfected cells were then infected with
inﬂuenza A for 3 h. After washing with PBS, the cells were ﬁxed
with 4% methanol-free formaldehyde (Polysciences Inc.,Warring-
ton, PA), permeabilized with 0.5% Triton 100 (Sigma) followed
by blocking with 5% bovine serum albumin (BSA). Slides were
washed twice with cold PBS after each treatment. Cells were
stained for 1 h with rabbit anti-human NS1ABP antibody (Abcam),
and the anti-mouse anti-inﬂuenza A nucleoprotein (Millipore,
Billerica,MA) followed by a secondary Alexa-488 conjugated
anti-rabbit antibody and Alexa-546 conjugated anti-mouse anti-
body (Invitrogen). The nuclei were stained with DAPI (Invitrogen).
The glass slides were mounted with Prolong Gold anti-fade
reagent (Invitrogen) and protected with cover slips. Images were
obtained using a Zeiss LSM510 confocal microscope with the
AxioImager system (Carl Zeiss, Obertochen, AG Germany).
Apoptotic death of cells infected with virus
A549 cells (1106) were transfected with for 48 h with 25–
100 nM of miRNA-548an inhibitor, mimic or scrambled oligonu-
cleotide. The transfected cells were then infected with inﬂuenza A
at MOI of 1 virus for 3 h. Cells were harvested, resuspended in
100 ml of annexin 1 binding buffer, and stained for 15 min at
room temperature with 5 ml of annexin V-FITC (BD Biosciences)
and 5 ml of propidium iodide (BD Biosciences) to detect apoptosis
and necrosis, respectively. After adding 300 ml of 1 binding
buffer to each sample, ﬂow cytometry analysis was performed
using a FACSCalibur. For gating purposes we have used unstained
cells, cells stained with only Annexin V, and cells stained only with
PI. Data were collected using Cellquest software (BD biosciences)
and analysis done with Win MIDI software.
Statistical analysis
Data from RT-PCR and ﬂow cytometry analysis of geometric
mean ﬂuorescent intensity (MFI) experiments are the average of
3–4 independent experiments with triplicate replicates. One-way
analysis of variance was used to analyze all data and post-hoc
pairwise multiple comparisons between means were performed
using the Holm-Sidak method with the statistical signiﬁcance of
po0.05. Statistical analysis was performed using the software
Sigma Plot version 11.0 for Windows (Systat Software, Chicago, IL).
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